Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results Life Science Investing
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress Life Science Investing
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights Life Science Investing
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates Life Science Investing
Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19 Life Science Investing
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update Life Science Investing
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook Life Science Investing
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 Life Science Investing
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Life Science Investing
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
